Literature DB >> 33710042

Explantation in Tissue Expander and Direct-to-Implant Reconstruction with Acellular Dermal Matrix: How to Avoid Early Reconstructive Failures.

Leslie E Cohen1, Jarrod T Bogue1, Julia Jin1, Joseph J Disa1.   

Abstract

BACKGROUND: In the United States, approximately 57,000 tissue expander/implant-based breast reconstructions are performed each year. Complete submuscular tissue expander coverage affords the best protection against implant exposure but can restrict lower pole expansion. The benefits of using acellular dermal matrix are enticing, but questions remain as to whether or not its presence increases reconstructive failures. The purpose of this study was to investigate predictors of explantation in those patients with acellular dermal matrix reconstructions and to discuss salvage techniques.
METHODS: An approved retrospective review was conducted of 137 patients undergoing 234 individual breast reconstructions over 4 years performed by a single plastic surgeon (J.D.) at a single institution. Patients who underwent implant-based reconstruction with either immediate placement of a tissue expander that was subsequently exchanged for a permanent implant at a second operation or immediate placement of a permanent implant when indicated were included.
RESULTS: One hundred thirty-seven patients who underwent 234 implant-based breast reconstructions using acellular dermal matrix met criteria. There was an overall 23 percent complication rate, including any cellulitis, seroma, skin necrosis, and hematoma formation. Significant preoperative risk factors for any postoperative complication included body mass index greater than 25 kg/m2 and a history of radiation therapy before acellular dermal matrix placement. Radiation therapy was found to be a significant risk factor for postoperative skin necrosis. Of explantations, many fluid cultures grew Gram-negative bacteria.
CONCLUSIONS: Skin necrosis is a serious risk factor for explantation in implant-based reconstruction with acellular dermal matrix. The reconstructive surgeon should consider early excision of any skin necrosis as soon as it is identified. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
Copyright © 2021 by the American Society of Plastic Surgeons.

Entities:  

Mesh:

Year:  2021        PMID: 33710042      PMCID: PMC9074855          DOI: 10.1097/PRS.0000000000007702

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  13 in total

1.  Nonexpansive immediate breast reconstruction using human acellular tissue matrix graft (AlloDerm).

Authors:  C Andrew Salzberg
Journal:  Ann Plast Surg       Date:  2006-07       Impact factor: 1.539

2.  Sterile "ready-to-use" AlloDerm decreases postoperative infectious complications in patients undergoing immediate implant-based breast reconstruction with acellular dermal matrix.

Authors:  Katie E Weichman; Stelios C Wilson; Pierre B Saadeh; Alexes Hazen; Jamie P Levine; Mihye Choi; Nolan S Karp
Journal:  Plast Reconstr Surg       Date:  2013-10       Impact factor: 4.730

3.  AlloDerm performance in the setting of prosthetic breast surgery, infection, and irradiation.

Authors:  Maurice Y Nahabedian
Journal:  Plast Reconstr Surg       Date:  2009-12       Impact factor: 4.730

4.  Acellular dermis-assisted breast reconstruction with the use of crescentric tissue expansion: a functional cosmetic analysis of 40 consecutive patients.

Authors:  Donald W Buck; Kamaldeep Heyer; David DiBardino; Kevin Bethke; John Y S Kim
Journal:  Aesthet Surg J       Date:  2010-03       Impact factor: 4.283

5.  Tissue expander breast reconstruction using prehydrated human acellular dermis.

Authors:  Vinay Rawlani; Donald W Buck; Sarah A Johnson; Kamaldeep S Heyer; John Y S Kim
Journal:  Ann Plast Surg       Date:  2011-06       Impact factor: 1.539

6.  Utility of acellular dermis-assisted breast reconstruction in the setting of radiation: a comparative analysis.

Authors:  Akhil K Seth; Elliot M Hirsch; Neil A Fine; John Y S Kim
Journal:  Plast Reconstr Surg       Date:  2012-10       Impact factor: 4.730

7.  Acellular human dermis implantation in 153 immediate two-stage tissue expander breast reconstructions: determining the incidence and significant predictors of complications.

Authors:  Anuja K Antony; Colleen M McCarthy; Peter G Cordeiro; Babak J Mehrara; Andrea L Pusic; Esther H Teo; Alexander F Arriaga; Joseph J Disa
Journal:  Plast Reconstr Surg       Date:  2010-06       Impact factor: 4.730

8.  Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications.

Authors:  Yoon S Chun; Kapil Verma; Heather Rosen; Stuart Lipsitz; Donald Morris; Pardon Kenney; Elof Eriksson
Journal:  Plast Reconstr Surg       Date:  2010-02       Impact factor: 4.730

9.  Acellular dermis-assisted prosthetic breast reconstruction versus complete submuscular coverage: a head-to-head comparison of outcomes.

Authors:  Hani Sbitany; Sven N Sandeen; Ashley N Amalfi; Mark S Davenport; Howard N Langstein
Journal:  Plast Reconstr Surg       Date:  2009-12       Impact factor: 4.730

10.  Early Surgical Site Infection Following Tissue Expander Breast Reconstruction with or without Acellular Dermal Matrix: National Benchmarking Using National Surgical Quality Improvement Program.

Authors:  Sebastian Winocour; Jorys Martinez-Jorge; Elizabeth Habermann; Kristine Thomsen; Valerie Lemaine
Journal:  Arch Plast Surg       Date:  2015-03-16
View more
  1 in total

1.  Reply: Explantation in Tissue Expander and Direct-to-Implant Reconstruction with Acellular Dermal Matrix: How to Avoid Early Reconstructive Failures.

Authors:  Leslie E Cohen; Joseph J Disa
Journal:  Plast Reconstr Surg       Date:  2022-04-01       Impact factor: 5.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.